Skip to main content

Table 1 Patient characteristics

From: Delay in seeking treatment before emergent heart failure readmission and its association with clinical phenotype

 

Early

(n = 1802)

Delayed

(n = 271)

P value

Patient characteristics

 Age, year

78.5 ± 11.1

77.5 ± 13.1

0.23

 Sex, female %

57.1

55.7

0.67

Past medical history

 Coronary artery disease, %

40.4

28.8

< 0.001

 Hypertension, %

64.3

60.9

0.27

 Diabetes mellitus, %

38.1

39.5

0.67

 Dyslipidemia, %

28.9

26.9

0.51

 Atrial fibrillation, %

35.8

45.1

0.003

 Dialysis, %

5.8

2.6

0.03

 Cerebrovascular disease, %

11.3

10.3

0.65

Primary etiology of heart failure

 Ischemic heart disease, %

28.2

24.4

0.19

 Hypertensive heart disease, %

17.9

11.1

0.005

 Arrhythmia, %

6.3

8.5

0.17

 Cardiomyopathy, %

10.6

11.8

0.55

 Valvular heart disease,%

20.3

23.2

0.27

 Others, %

16.8

21.0

0.08

Laboratory data at admission

 Hb, mg/dl

11.6 ± 2.3

11.4 ± 2.2

0.09

 BNP, pg/ml

800 (458 to 1475)

800 (428 to 1412)

0.14

 Cr, mg/dl

1.26 (0.90 to 1.91)

1.26 (0.92 to 1.76)

0.14

Echocardiographic findings

 LVEF, %

42.0 ± 15.9

42.4 ± 16.8

0.74

 Heart failure with preserved ejection fraction, %

33.1

36.2

0.27

 Heart failure with mid-range ejection fraction, %

21.5

17.3

 Heart failure with reduced ejection fraction, %

45.4

46.5

Vital signs at admission

 Heart rate, bpm

98.6 ± 26.3

91.8 ± 24.4

< 0.001

 Respiration rate, times/m

23.2 ± 9.7

20.4 ± 8.4

< 0.001

 Systolic blood pressure, mmHg

150.4 ± 37.4

138.3 ± 33.3

< 0.001

 Percutaneous saturation of oxygen

93.3 ± 10.8

94.1 ± 12.9

0.25

  1. Hb hemoglobin concentration, BNP plasma brain natriuretic peptide concentration, Cr serum creatinine concentration, LVEF left ventricular ejection fraction